Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer
Benjamin A. Gartrell, Robert E. Coleman, Karim Fizazi, Kurt Miller, Fred Saad, Cora N. Sternberg, Matthew D. Galsky
Dive into the research topics of 'Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer'. Together they form a unique fingerprint.